Israel Discount Bank of New York’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Israel Discount Bank of New York’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,070	Closed	-$6K	–	418
2019 Q1	$6K	Hold	1,070	–	–	﹤0.01%	399
2018 Q4	$14K	Hold	1,070	–	–	0.01%	360
2018 Q3	$21K	Sell	1,070 -630	-37%	-$13.4K	0.01%	340
2018 Q2	$43K	Hold	1,700	–	–	0.03%	302
2018 Q1	$34K	Hold	1,700	–	–	0.02%	339
2017 Q4	$34K	Hold	1,700	–	–	0.02%	345
2017 Q3	$35K	Buy	1,700 +625	+58%	+$10.6K	0.03%	330
2017 Q2	$16K	Sell	1,075 -35	-3%	-$583	0.01%	376
2017 Q1	$18K	Hold	1,110	–	–	0.01%	381
2016 Q4	$14K	Buy	+1,110	New	+$20.7K	0.01%	415

Other funds holding DPLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Israel Discount Bank of New York's DPLO Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 1,070 shares — an estimated $6K sold.

Israel Discount Bank of New York first reported a position in DPLO in Q4 2016 and held it in 10 quarters. The position peaked at $43K in Q2 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

Israel Discount Bank of New York reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
Israel Discount Bank of New York sold 1,070 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $6K.
Israel Discount Bank of New York first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 10 quarters.
Israel Discount Bank of New York's DIPLOMAT PHARMACY, INC. position peaked at $43K in Q2 2018.
131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.